SG11201808976WA - Method of producing a recombinant protein - Google Patents
Method of producing a recombinant proteinInfo
- Publication number
- SG11201808976WA SG11201808976WA SG11201808976WA SG11201808976WA SG11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA
- Authority
- SG
- Singapore
- Prior art keywords
- glaxosmithkline
- road
- international
- hertfordshire
- recombinant protein
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 5
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000002023 wood Substances 0.000 abstract 5
- 241000581479 Apodichthys Species 0.000 abstract 4
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 101710141454 Nucleoprotein Proteins 0.000 abstract 1
- 238000010364 biochemical engineering Methods 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332636P | 2016-05-06 | 2016-05-06 | |
| US201662338045P | 2016-05-18 | 2016-05-18 | |
| PCT/EP2017/060654 WO2017191255A1 (en) | 2016-05-06 | 2017-05-04 | Method of producing a recombinant protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201808976WA true SG11201808976WA (en) | 2018-11-29 |
Family
ID=58765814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201808976WA SG11201808976WA (en) | 2016-05-06 | 2017-05-04 | Method of producing a recombinant protein |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11098312B2 (enExample) |
| EP (1) | EP3452496A1 (enExample) |
| JP (2) | JP2019516371A (enExample) |
| KR (1) | KR102504317B1 (enExample) |
| CN (1) | CN109071611B (enExample) |
| AU (1) | AU2017260277A1 (enExample) |
| BR (1) | BR112018072043A2 (enExample) |
| CA (1) | CA3023025A1 (enExample) |
| IL (1) | IL262544A (enExample) |
| MX (1) | MX2018013562A (enExample) |
| RU (1) | RU2742006C2 (enExample) |
| SG (1) | SG11201808976WA (enExample) |
| TW (1) | TWI794170B (enExample) |
| WO (1) | WO2017191255A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7517707B2 (ja) * | 2019-02-15 | 2024-07-17 | オンコシミス バイオテック プライベート リミテッド | タンパク質分泌増強のための細菌発現ベクター |
| KR102094480B1 (ko) | 2019-05-27 | 2020-04-01 | (주)엘에스케이화인텍스 | 재사용 가능한 미세 먼지 항균 마스크 |
| CN110551199B (zh) * | 2019-09-26 | 2022-01-25 | 杭州纽龙日尚生物制品有限公司 | 一种提高工程菌分泌表达重组人表皮生长因子的方法 |
| KR20240021234A (ko) * | 2021-06-10 | 2024-02-16 | 펠리칸 테크놀로지 홀딩스, 인크. | 재조합 단백질 발현을 위한 박테리아 숙주 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1701119A (zh) * | 2002-09-20 | 2005-11-23 | Cym1P有限公司 | 增加宿主细胞重组多肽产量的方法 |
| GB0426160D0 (en) * | 2004-11-29 | 2004-12-29 | Era Plantech S L | Production of proteins |
| EP1981979A4 (en) * | 2006-01-31 | 2009-07-29 | Republic Of Korea Republic Of | PROCESS FOR PRODUCING A SOLUBLE NATIVE FORM OF RECOMBINANT PROTEIN USING THE SIGNAL SEQUENCE AND A SECRETION ENHANCING AGENT |
| GB0602173D0 (en) | 2006-02-03 | 2006-03-15 | Avecia Ltd | Expression system |
| EP2176291A1 (en) * | 2007-08-10 | 2010-04-21 | Wacker Chemie AG | Expression of full length igg and secretion into the culture medium of prokaryotic cells |
| RU2488635C1 (ru) * | 2012-03-22 | 2013-07-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития | Способ получения рекомбинантного антиангиогенного полипептида |
| SG10201602115PA (en) * | 2012-09-19 | 2016-05-30 | Univ Singapore | Codon optimization of a synthetic gene(s) for protein expression |
-
2017
- 2017-05-04 RU RU2018137305A patent/RU2742006C2/ru active
- 2017-05-04 KR KR1020187034736A patent/KR102504317B1/ko active Active
- 2017-05-04 TW TW106114729A patent/TWI794170B/zh active
- 2017-05-04 BR BR112018072043-7A patent/BR112018072043A2/pt not_active Application Discontinuation
- 2017-05-04 JP JP2018558148A patent/JP2019516371A/ja active Pending
- 2017-05-04 AU AU2017260277A patent/AU2017260277A1/en not_active Abandoned
- 2017-05-04 EP EP17725188.1A patent/EP3452496A1/en not_active Withdrawn
- 2017-05-04 MX MX2018013562A patent/MX2018013562A/es unknown
- 2017-05-04 CA CA3023025A patent/CA3023025A1/en not_active Abandoned
- 2017-05-04 CN CN201780028031.XA patent/CN109071611B/zh active Active
- 2017-05-04 WO PCT/EP2017/060654 patent/WO2017191255A1/en not_active Ceased
- 2017-05-04 SG SG11201808976WA patent/SG11201808976WA/en unknown
- 2017-05-04 US US16/098,890 patent/US11098312B2/en active Active
-
2018
- 2018-10-24 IL IL262544A patent/IL262544A/en unknown
-
2022
- 2022-02-03 JP JP2022015944A patent/JP2022070902A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN109071611A (zh) | 2018-12-21 |
| KR102504317B1 (ko) | 2023-02-24 |
| CA3023025A1 (en) | 2017-11-09 |
| JP2019516371A (ja) | 2019-06-20 |
| RU2018137305A3 (enExample) | 2020-06-08 |
| CN109071611B (zh) | 2022-11-01 |
| TW201805298A (zh) | 2018-02-16 |
| TWI794170B (zh) | 2023-03-01 |
| RU2018137305A (ru) | 2020-06-08 |
| IL262544A (en) | 2018-12-31 |
| AU2017260277A1 (en) | 2018-11-22 |
| MX2018013562A (es) | 2019-03-14 |
| WO2017191255A1 (en) | 2017-11-09 |
| EP3452496A1 (en) | 2019-03-13 |
| KR20190003694A (ko) | 2019-01-09 |
| JP2022070902A (ja) | 2022-05-13 |
| BR112018072043A2 (pt) | 2019-02-12 |
| RU2742006C2 (ru) | 2021-02-01 |
| US20190177734A1 (en) | 2019-06-13 |
| US11098312B2 (en) | 2021-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201809857TA (en) | Anti-CTLA-4 Antibodies | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201903830TA (en) | Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies | |
| SG11201903302UA (en) | Bispecific heterodimeric fusion proteins containing il-15/il-15ralpha fc-fusion proteins and pd-1 antibody fragments | |
| SG11201810430WA (en) | Heater assembly for an aerosol-generating system | |
| SG11201808724SA (en) | Anti-tim-3 antibodies and compositions | |
| SG11201810509PA (en) | Anti-pd-l1 antibodies | |
| SG11201804460PA (en) | Calibration and detection techniques in haptic systems | |
| SG11201808797XA (en) | T cell receptors | |
| SG11201808821WA (en) | Agonistic antibodies that bind human cd40 and uses thereof | |
| SG11201909070RA (en) | System for hydrocarbon recovery | |
| SG11201808976WA (en) | Method of producing a recombinant protein | |
| SG11201907776WA (en) | Replication lag-constrained deletion of data in a large-scale distributed data storage system | |
| SG11201811659PA (en) | Systems and methods for determining an estimated time of arrival | |
| SG11201811604UA (en) | System and method for real-time transcription of an audio signal into texts | |
| SG11201803918VA (en) | Production of steviol glycosides in recombinant hosts | |
| SG11201808992UA (en) | Compositions and methods for the detection of host cell proteins | |
| SG11201906359SA (en) | Compositions and methods for maturation of oocytes in vitro | |
| SG11201806432PA (en) | Methods for assessing risk of developing colorectal cancer | |
| SG11201901172QA (en) | A method for manufacturing a fuel component | |
| SG11201811238YA (en) | Systems and methods for stations loading and display | |
| SG11201805494WA (en) | Mutated von willebrand factor | |
| SG11201803565UA (en) | Cd131 binding proteins and uses thereof | |
| SG11201903602RA (en) | Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody |